Dapsone
Contents
Description
Dapsone is a sulfone antibiotic with anti-inflammatory properties used primarily for dermatological conditions. It is the first-line treatment for dermatitis herpetiformis, a chronic autoimmune blistering skin condition associated with celiac disease. The drug works by inhibiting neutrophil function and reducing inflammatory responses in the skin.
Indications & Therapeutic Use
dermatitis herpetiformis, leprosy, Pneumocystis jirovecii pneumonia prophylaxis
Linked Diseases:
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Dapsone — GNH India
46 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | dapsone |
| Brands | 1 brand available |
| Active Ingredient | dapsone |
| Drug Class | dermatitis herpetiformis |
| Manufacturer | Allergan |
| Dosage Forms | oral tablet 25mg, 50mg, 100mg; topical gel 5%, 7.5% |
| Medical Code | D10AF01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |